✦ LIBER ✦

(−)-Oleocanthal as a c-Met Inhibitor for the Control of Metastatic Breast and Prostate Cancers

✍ Scribed by Elnagar, Ahmed; Sylvester, Paul; El Sayed, Khalid

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

c-Met as a target for human cancer and c

✍ James G. Christensen; Jon Burrows; Ravi Salgia 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 388 KB

A phase II trial of a selective c-Met in

✍ Kang, Yoon-Koo; Muro, Kei; Ryu, Min-Hee; Yasui, Hirofumi; Nishina, Tomohiro; Ryo 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 234 KB

Leukopenia as a risk factor for osteonec

✍ Hideyo Miyazaki; Hiroaki Nishimatsu; Haruki Kume; Motofumi Suzuki; Tetsuya Fujim 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Second- and Third-generation Aromatase I

✍ Elledge, R.M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 94 KB

The efficacy of bevacizumab plus paclita

✍ Wang, Xuan; Huang, Chun; Li, Man; Gu, Yanjun; Cui, Yanfen; Li, Yan 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 395 KB

Molecular Pathways: Blockade of the PRLR

✍ Damiano, J. S.; Wasserman, E. 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 815 KB